dc.contributor.advisor | Moreno Fergusson, María Elisa | |
dc.contributor.author | Camelo Hernández, Yamid Ferney | |
dc.date.accessioned | 2015-05-15T21:29:43Z | |
dc.date.available | 2015-05-15T21:29:43Z | |
dc.date.created | 2015 | |
dc.date.issued | 2015-05-15 | |
dc.identifier.citation | Calzone KA, Jenkins J, Yates J, Cusack G, Wallen GR, Liewehr
DJ, Steinberg SM, McBride C. Survey of nursing integration
of genomics into nursing practice. Journal of Nursing Scholarship 2012;
44(4): 428-36. | |
dc.identifier.citation | Jenkins J, Grady PA, Collins FS. Nurses and the genomic revolution.
Journal of Nursing Scholarship 2005; 37(2): 98-101. | |
dc.identifier.citation | Loescher L, Merkle C. The Interface of Genomic Technologies and Nursing.
Journal of Nursing Scholarship 2005; 37(2): 111-119 | |
dc.identifier.citation | Ley 1392/2010 de 2 julio, por la cual se reconocen reconocen las
enfermedades huérfanas. (Diario Oficial 47758 de Julio 2 de 2010). | |
dc.identifier.citation | Calzone KA, Jenkins J, Culp S, Bonham VL Jr, Badzek L.
National nursing workforce survey of nursing attitudes, knowledge and
practice in genomics. Personalized medicine 2013; 10(7): 1-16. | |
dc.identifier.citation | Feetham S, Thomson EJ, Hinshaw AS. Nursing leadership in genomics for
health and society. Journal of Nursing Scholarship 2005; 37(2): 102-10. | |
dc.identifier.citation | Calzone KA, Jenkins J, Bakos AD, Cashion AK, Donaldson N, Feero
WG, Feetham S, Grady PA, Hinshaw AS, Knebel AR, Robinson N, Ropka
ME, Seibert D, Stevens KR, Tully LA, Webb JA.
A blueprint for genomic nursing science. Journal of Nursing
Scholarship 2013; 45(1):96-104. | |
dc.identifier.citation | Luján J, Moreno L. Biotecnología y sociedad: conflicto, desarrollo y
regulación. Instituto de Estudios Sociales Avanzados. Disponible en:
http://digital.csic.es/bitstream/10261/1992/1/dt-9305.pdf | |
dc.identifier.citation | Flória-Santos M, Ramos E. Genomic-based nursing care for women with
Turner Syndrome: genomic-based nursing care. Revista latinoamericana de
Enfermagem 2006; 14(5): 645-650. | |
dc.identifier.citation | Calzone KA, Jenkins J, Culp S, Bonham VL Jr, Badzek L.
National nursing workforce survey of nursing attitudes, knowledge and
practice in genomics. Personalized medicine 2013; 10(7): 1-16. | |
dc.identifier.citation | Meikle PJ, Hopwood JJ. Lysosomal storage disorders: emerging therapeutic
options require early diagnosis. European Journal of Pediatrics. 2003; 162(1):S34-7. | |
dc.identifier.citation | Parkinson-Lawrence EJ, Shandala T, Prodoehl M, Plew R, Borlace
GN, Brooks DA. Lysosomal Storage Disease: Revealing Lysosomal
Function and Physiology. Physiology (Bethesda). 2010; 25(2):102-15. | |
dc.identifier.citation | Wenger DA, Luzi P, Rafi MA. Lysosomal Storage Diseases: Heterogeneous
Group of Disorders. BioImpacts. 2013; 3(4):145-7. | |
dc.identifier.citation | Vellodi A. Lysosomal storage disorders. British Journal of Haematology.
2005; 128(4):413-31. | |
dc.identifier.citation | Qu Y. Lysosomal storage disorders. Journal of pekin university Health
sciences2006; 38(1):100-2. | |
dc.identifier.citation | Ballabio A, Gieselmann V. Lysosomal disorders:
from storage to cellular damage. Biochimica et Biophysica Acta.2009;
1793(4):684-96. | |
dc.identifier.citation | Lodwig J, Peers K. Introduction to inherited metabolic diseases. Nursing
Times 2013; 109(46): 28 | |
dc.identifier.citation | Klein AD, Futerman AH. Lysosomal Storage Disorders: old diseases,
present and future challenges. Pediatric endocrinology reviews 2013; 11(1):
59-63. | |
dc.identifier.citation | Wilcox W. Lysosomal storage disorders: the need for better pediatric
recognition and comprehensive care. Journal of Pediatrics 2004;144(5):S3-
S14 | |
dc.identifier.citation | .Fuller M, Meikle PJ, Hopwood JJ. Epidemiology of lysosomal storage
diseases: an overview. In: Mehta A, Beck M, Sunder-Plassmann G, editors.
Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford
PharmaGenesis, 2006. Chapter 2 | |
dc.identifier.citation | Poupetová H, Ledvinová J, Berná L, Dvoráková L, Kozich V, Elleder M.The
birth prevalence of lysosomal storage disorders in the Czech Republic:
comparison with data in different populations. Journal of Inherited metabolic
disease. 2010; 33(4):387-96. | |
dc.identifier.citation | Pinto R, Caseiro C, Lemos M, Lopes L, Fontes A, Ribeiro H, Pinto E, Silva
E, Rocha S, Marcão A, Ribeiro I, Lacerda L, Ribeiro G, Amaral O, Sá
Miranda MC. Prevalence of lysosomal storage diseases in Portugal.
European Journal of Human Genetics. 2004; 12(2):87-92 | |
dc.identifier.citation | Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence
of lysosomal storage disorders. JAMA. 1999; 20(3):249-54 | |
dc.identifier.citation | Sheth J, Patel P, Sheth F, Shah R.Lysosomal storage disorders. Indian
Pediatrics. 2004; 41(3):260-5. | |
dc.identifier.citation | Khatiwada B, Pokharel A. Lysosomal Storage Disease. Journal of Nepal Medical Association. 2009; 48(175):242-5. | |
dc.identifier.citation | Schultz ML, Tecedor L, Chang M, Davidson BL. Clarifying lysosomal
storage diseases. Trends in Neurosciences. 2011; 34(8): 401-10 | |
dc.identifier.citation | Minsalud.gov.co [Internet]. Boletín de Prensa No 052 del 26 de febrero de
2014 [actualizado febrero 2015; citado 25 febrero de 2015]. Disponible en:
http://www.minsalud.gov.co/Paginas/-Colombia-avanza-en-laidentificaci%C3%B3n-de-los-pacientes-con-enfermedadeshu%C3%A9rfanas.aspx | |
dc.identifier.citation | Boyes L. What do nurses need to know about genetics? Nursing Times
2013; 109 (49): 24 | |
dc.identifier.citation | Gutiérrez L. Avances en el tratamiento de las enfermedades lisosomales en
la infancia. Revista de Neurología 2006; 43(1): S137-S144 | |
dc.identifier.citation | Lara R, Juárez C, Medina C. Terapia de las enfermedades por depósito
lisosomal: actualidad y perspectivas. Revista de investigación clínica 2011;
63(6):651-658. | |
dc.identifier.citation | Freedman R, Sahhar M, Curnow L, Lee J, Peters H. Receiving Enzyme
Replacement Therapy for a Lysosomal Storage Disorder: A Preliminary
Exploration of the Experiences of Young Patients and Their Families.
Journal of genetic counseling 2013; 22(4): 517-32 | |
dc.identifier.citation | Scarpa M, Almássy Z, Beck M, Bodamer O, Bruce L, Meirleir L, Guffon N,
Guillén-Navarro E, Hensman P, Jones S, Kamin W, Kampmann C, Lampe
C, Lavery C, Teles E, Link B, Lund A, Malm G, Pitz S, Rothera M, Stewart
C, Tylki-Szymańska A, Ploeg A, Walker R, Zeman J, Wraith
J.Mucopolysaccharidosis type II: European recommendations for the
diagnosis and multidisciplinary management of a rare disease.Orphanet
Journal of Rare Diseases 2011; 6(72): 1-18. | |
dc.identifier.citation | Hayes R, Grinzaid K, Duffey E, Elsas II L. The impact of Gaucher disease
and its treatment on quality of life. Quality of Life Research 1998; 7(6):
521-34 | |
dc.identifier.citation | .Stewart S, Peers K. Rare diseases: what do you need to know? Nursing
Times 2013; 109(45): 12-14 | |
dc.identifier.citation | Knight A, Senior T. The common problem of rare disease in general
practice. Medical Journal of Australia 2006; 185(2): 82 | |
dc.identifier.citation | Anderson M, Elliott EJ, Zurynski YA.
Australian families living with rare disease: experiences of diagnosis, health
services use and needs for psychosocial support. Orphanet journal of rare
diseases 2013; (11): 8-22. | |
dc.identifier.citation | Andria G, Limongelli G. Diagnosis and management of lysosomal storage
disorders. Three key words: early, multidisciplinary, and network.
Cardiogenetics 2013; 3(1): 1 | |
dc.identifier.citation | Resolución 430/2013 de 23 febrero, por el cual se define el listado de
enfermedades huérfanas. (Diario Oficial 00271 de febrero 23 de 2013). | |
dc.identifier.citation | Ley 1751/2015 de 16 de febrero,por medio de la cual se regula el derecho
fundamental a la salud. (Diario Oficial 49427 de febrero 16 de 2015) | |
dc.identifier.citation | Hennekam RC. Care for patients with ultra-rare disorders. European journal
of medical genetics 2011; 54(3):220-4 | |
dc.identifier.citation | .Žnidar I, Collin-Histed T, Niemeyer P, Parkkinen J, Lauridsen AG, Zariņa
S, Cohen Y, Manuel J. The European Gaucher Alliance:
a survey of member patient organisations' activities, healthcare evironments
and concerns. Orphanet Journal of Rare Diseases 2014; 9(1): 134-149. | |
dc.identifier.citation | American Nurses Association. Essentials of genetic and genomic nursing:
competencies, curricula guidelines, and outcome indicators. 2 ed. Maryland;
2008. | |
dc.identifier.citation | Howington L, Riddlesperger K, Cheek DJ.
Essential nursing competencies for genetics and genomics: implications for
critical care. Critical care nurse 2011; 31(5): 1-9. | |
dc.identifier.citation | Jenkins J, Calzone KA. Establishing the essential nursing competencies for
genetics and genomics. Journal of Nursing Scholarship 2007; 39(1):10-6. | |
dc.identifier.citation | Aiello-Laws LB. Genetics and genomics nursing has arrived! Oncology
Nursing Forum 2013; 40(1):20-1. | |
dc.identifier.citation | Calzone KA, Jenkins J, Nicol N, Skirton H, Feero WG, Green ED.
Relevance of genomics to healthcare and nursing practice. Journal of
Nursing Scholarship 2013; 45(1): 1-2. | |
dc.identifier.citation | Thompson HJ, Brooks MV.
Genetics and genomics in nursing: evaluating Essentials implementation.
Nurse Education Today 2011; 31(6):623-7. | |
dc.identifier.citation | Prows C, Glass M, Nicol M.J, Skirton H, Williams J. Genomics in Nursing
Education. Journal of Nursing Scholarship 2005; 37(3):196-202. | |
dc.identifier.citation | Ley 266/1996 de 25 enero, Por la cual se reglamenta la profesión de
enfermería en Colombia. (Diario Oficial No. 42.710, del 5 de febrero de 1996). | |
dc.identifier.citation | Roy C. The Roy Adaptation Model. 3 ed. New Jersey: Pearson; 2009 | |
dc.identifier.citation | Buckner E, Hayden S. Synthesis of midle range theory of adapting to
chronic conditions: A lifelong process and a common journey. En: Roy C.
Middle Range Theories for evidence based practice. New York: Springer
Publishing Company, 2014. P. 277 - 307 | |
dc.identifier.citation | Stryker VL, Kreps C. Fabry disease. The american journal of Nursing 2001;
101(4): 39-44. | |
dc.identifier.citation | Henderson SL, Packman W, Packman S. Psychosocial aspects of patients
with Niemann-Pick disease, Type B. American Journal of medical genetics
Part A 2009; 149A (11):2430–2436. | |
dc.identifier.citation | Crosbie T, Packman W, Packman S. Psychological aspects of patients with
Fabry disease. Journal of inherited metabolic disease 2009; 32(6):745–753. | |
dc.identifier.citation | Packman W, Crosbie T, Riesner A. Psychological complications of patients
with Gaucher disease. Journal of inherited methabolic diseases 2006;
29(1):99-105. | |
dc.identifier.citation | Laney D, Gruskin D, Fernhoff P, Cubells J, Ousley O, Hipp H, Mehta A.
Social-adaptive and psychological functioning of patients affected by Fabry
disease. Journal of Inherited Metabolic Diseases 2010; 33 (3):S73–S81 | |
dc.identifier.citation | Triomphe TJ. Glycogen storage disease:
a basic understanding and guide to nursing care. Journal of pediatric
Nursing 1997; 12(4):238-49. | |
dc.identifier.citation | Dellve L, Samuelsson L, Tallborn A, Fasth A, Hallberg L. Stress and wellbeing among parents of children with rare diseases: a prospective
intervention study. Journal of Advanced Nursing 2006; 53(4): 392–402. | |
dc.identifier.citation | Herdman T. H. NANDA Internacional, diagnósticos enfermeros, definiciones
y clasificación 2012-2014 elsevier. 2012 | |
dc.identifier.citation | Bulechek G, Butcher H, Dochterman J. Clasificación de intervenciones de
enfermería (NIC) quinta edición. Elsevier. 2008 | |
dc.identifier.citation | Smith C. Understanding neurofibromatosis type 2. Nursing Times 2013;
109(48):19 | |
dc.identifier.citation | Hunt J. Treatment of inherited cardiac conditions. Nursing times 2013;
109(45): 16-18 | |
dc.identifier.citation | Ceravolo F, Mascaro I, Sestito S, Pascale E, Lauricella A, Dizione E,
Concolino D. Home treatment in paediatric patients with Hunter syndrome:
the first Italian experience. Italian Journal of Pediatrics 2013; 39(53):1-3. | |
dc.identifier.citation | Enfermedadesraras-shire [Internet]. Shire [actualizado enero 2015; citado
25 febrero de 2015]. Disponible en: http://enfermedadesraras-shire.com/# | |
dc.identifier.citation | Orpha.net [Internet]. Orphanet [actualizado febrero 2015; citado 25 febrero
de 2015].Disponible en: http://www.orpha.net/consor/cgi-bin/index.php. | |
dc.identifier.citation | Acopel. Org [Internet]. Acopel [actualizado enero 2015; citado 25 febrero de
2015]. Disponible en:http://www.acopel.org.co/web/. | |
dc.identifier.citation | Ramaswami U, Stull D, Parini R, Pintos-Morell G, Whybra C, Kalkum G,
Rohrbach M, Raluy-Callado M, Beck M, Chen W, Wiklund I. Measuring
patient experiences in Fabry disease: validation of the Fabry-specific
Pediatric Health and Pain Questionnaire (FPHPQ).Health and Quality of Life
Outcomes 2012; 10(116): 1-9. | |
dc.identifier.citation | Lobiondo-Wood G, Haber J. Nursing Research. Methods and critical
appraisal for Evidence based practice. 4 ed. Philadelphia (PA): Mosby
Elsevier; 2006. | |
dc.identifier.citation | Polit-Hungler. Investigación científica en ciencias de la salud. 6 Ed.
McGraw-Hill; 2000. | |
dc.identifier.uri | http://hdl.handle.net/10818/16098 | |
dc.description | 54 páginas incluye ilustraciones y diagramas | |
dc.description.abstract | A partir del descubrimiento del genoma humano en el año 2003, que tuvo como propósito descifrar el código genético de los cromosomas, la atención de la salud está cambiando en aspectos relacionados con la prevención de enfermedades, el diagnóstico y el tratamiento. [1, 2, 3] El estudio del genoma humano ha ayudado a identificar el origen de muchas enfermedades, entre las cuales se encuentran las enfermedades raras o huérfanas, las cuales tienen una prevalencia menor de 1 por cada 5000 personas. Estas enfermedades son de especial interés para el gobierno nacional, por la condición de ser crónicas debilitantes, graves, amenazan la vida de las personas afectadas, y tienen un elevado costo de atención. [4] Dadas estas particularidades, representan un reto para la atención en salud evidenciándose la necesidad de indagar más sobre ellas para brindar atención integral a los pacientes y sus familias con el fin de mejorar su calidad de vida. | es_CO |
dc.language.iso | es | es_CO |
dc.publisher | Universidad de la Sabana | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.source | Intellectum Repositorio Universidad de la Sabana | |
dc.source | Universidad de la Sabana | |
dc.subject | Enfermería | |
dc.subject | Atención al enfermo | |
dc.subject | Atención médica -- Colombia | |
dc.title | Cuidado de enfermería a las personas con enfermedades de depósito lisosomal y sus familias | es_CO |
dc.type | Thesis | es_CO |
dc.type | info:eu-repo/semantics/bachelorThesis | |
dc.publisher.program | Enfermería | |
dc.publisher.department | Facultad de Enfermería y Rehabilitación | |
dc.creator.degree | Enfermero | |